You are here: Home / Documents / Policy Documents / nord-study-fda-approval


PDF document icon NORD study of FDA approval of orphan drugs.pdf — PDF document, 465 kB (476251 bytes)


The National Organization for Rare Disorders (NORD) provides advocacy, education and other services to improve the lives of all people affected by rare diseases. More >

NORD Get our latest e-news

Copyright ©2015 NORD - National Organization for Rare Disorders, Inc. All rights reserved.
The following trademarks/registered service marks are owned by NORD: NORD, National Organization for Rare Disorders, the NORD logo, RareConnect. .